"22 Years of predictive testing for Huntington’s disease: the experience of the UK Huntington’s Prediction Consortium" European Journal of Human Genetics (2016) 24, 1515; doi:10.1038/ejhg.2016.81 Corrigendum: 15 September 2016 European Journal of Human Genetics (2016) 24, 1515 (2016) doi:10.1038/ejhg.2016.81 Corrigendum: 12 October 2017 European Journal of Human Genetics (2017) 25, 1290 (2017) doi:10.1038/ejhg.2017.139Peer reviewedPostprintPostprintPostprintPostprintPostprintPostprintPostprintPostprin
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
BACKGROUND: Huntington's disease (HD) is a rare triplet repeat (CAG) disorder. Advanced, multi-c...
A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommend...
Huntington’s disease (HD) is a progressive neurodegenerative condition. At-risk individuals have acc...
A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommend...
Data on all presymptomatic genetic tests for Huntington’s disease (HD) in the UK have been collected...
A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommend...
Background: It is well known in Huntington’s disease that cytosine-adenine-guanine expansion and age...
BACKGROUND: Characterizing progression in Huntington's disease is important for study the natural ...
Between 1994 and 1998, the 23 UK genetics departments, which form the UK Huntington's Disease Consor...
BackgroundIt is well known in Huntington's disease that cytosine-adenine-guanine expansion and age a...
Pre-symptomatic testing for Huntington's disease (HD) has been available as a clinical service in th...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
BACKGROUND: Huntington's disease (HD) is a rare triplet repeat (CAG) disorder. Advanced, multi-c...
A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommend...
Huntington’s disease (HD) is a progressive neurodegenerative condition. At-risk individuals have acc...
A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommend...
Data on all presymptomatic genetic tests for Huntington’s disease (HD) in the UK have been collected...
A consistent feature of predictive testing guidelines for Huntington's disease (HD) is the recommend...
Background: It is well known in Huntington’s disease that cytosine-adenine-guanine expansion and age...
BACKGROUND: Characterizing progression in Huntington's disease is important for study the natural ...
Between 1994 and 1998, the 23 UK genetics departments, which form the UK Huntington's Disease Consor...
BackgroundIt is well known in Huntington's disease that cytosine-adenine-guanine expansion and age a...
Pre-symptomatic testing for Huntington's disease (HD) has been available as a clinical service in th...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
BACKGROUND: Huntington's disease (HD) is a rare triplet repeat (CAG) disorder. Advanced, multi-c...